Pediatric migraine: Neurodevelopmental mechanisms, clinical phenotypes, and modern therapeutics
Abstract
Migraine is among the most prevalent neurological disorders in children and adolescents and is a leading cause of functional disability, school absenteeism, and impaired quality of life. Pediatric migraine is not merely a younger manifestation of the adult disease; rather, it exhibits distinct clinical phenotypes, developmental neurobiology, triggers, and treatment responses. The growing recognition of its long-term burden underscores the need for updated, pediatric-focused, evidence-based guidance. This narrative review synthesizes contemporary evidence on pediatric migraine across the lifespan, integrating epidemiology, genetic susceptibility, and age-dependent neurobiological mechanisms. Key clinical features, including migraine equivalents and episodic syndromes associated with migraine, are discussed alongside diagnostic considerations using the International Classification of Headache Disorders, third edition, and validated pediatric disability assessment tools. Acute and preventive management strategies are reviewed in detail, encompassing optimized use of non-steroidal anti-inflammatory drugs and triptans, antiemetics, nerve blocks, neuromodulation devices, and emerging targeted therapies such as calcitonin gene-related peptide monoclonal antibodies and gepants. Evidence-based non-pharmacological interventions, including lifestyle optimization, sleep hygiene, cognitive-behavioral therapy, and comorbidity management, are also integral components of care. Pediatric…
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.